Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Business
STAT+

These three doctors are going the startup route early in their careers

By Jonathan Saltzman — Boston GlobeNov. 26, 2018

Reprints
Dr. Ailis Tweed Kent
Dr. Ailis Tweed-Kent, chief executive of Cocoon Biotech. Jonathan Wiggs/The Boston Globe

One graduated from Harvard Medical School but never practiced medicine, deciding at age 26 to develop a device to fight obesity.

Another graduated from Johns Hopkins University School of Medicine and promptly joined the drug industry, recently helping to engineer the sale of a Cambridge startup in a deal worth up to $775 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jonathan Saltzman — Boston Globe

Tags

There is no epidemic of autism. It’s an epidemic…
There is no epidemic of autism. It’s an epidemic of need
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Why you get paid to donate plasma but not…
Why you get paid to donate plasma but not blood
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EU delays pharma legislation again; India cancels license…
Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to…
J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug

Recommended Stories